CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Risperidone

利培酮 杂质对照品Risperidone Impurities

EP36 个杂质条目36 impurity entries

本页汇总 利培酮 的 36 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 36 impurity reference standards of Risperidone with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 利培酮(Risperidone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesCharacterization of bonded stationary phase performance as a function of qualitative and quantitative chromatographic factors in chaotropic chromatography with risperidone and its impurities as model substances
    Analytical and bioanalytical chemistry · 2018 · Čolović J et al.  ·  PMID 29770836  ·  DOI
  2. 杂质研究Impurity studiesHigh performance liquid chromatographic and thin layer densitometric methods for the determination of risperidone in the presence of its degradation products in bulk powder and in tablets
    Journal of pharmaceutical and biomedical analysis · 2005 · El-Sherif ZA et al.  ·  PMID 15620522  ·  DOI
  3. 杂质研究Impurity studiesStability indicating HPLC determination of risperidone in bulk drug and pharmaceutical formulations
    International journal of analytical chemistry · 2011 · Dedania ZR et al.  ·  PMID 22007220  ·  DOI
  4. 分析方法Analytical MethodsDetermination of Chlorpromazine, Haloperidol, Levomepromazine, Olanzapine, Risperidone, and Sulpiride in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
    International journal of analytical chemistry · 2018 · Khelfi A et al.  ·  PMID 30245722  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisAn efficient synthesis of risperidone via stille reaction: antipsychotic, 5-HT2, and dopamine-D2-antagonist
    Archives of pharmacal research · 2005 · Kim DM et al.  ·  PMID 16212230  ·  DOI

利培酮 —— 原料药与杂质对照品Risperidone — drug substance & impurities

共 37 个条目(含原料药本体)37 items incl. the drug substance
Risperidone structure
EP原料药 APIAPI
利培酮Risperidone
Risperidone
CAS No.106266-06-2
Chemical FormulaC23H27FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 7(Risperidone EP Impurity A) structure
EPA
利培酮杂质7(利培酮EP杂质A)Risperidone Impurity 7(Risperidone EP Impurity A)
Risperidone Impurity 7(Risperidone EP Impurity A)
CAS No.691007-09-7
Chemical FormulaC23H28F2N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 1 (Risperidone EP Impurity B) structure
EPB
利培酮杂质1 (利培酮EP杂质B)Risperidone Impurity 1 (Risperidone EP Impurity B)
Risperidone Impurity 1 (Risperidone EP Impurity B)
CAS No.132961-05-8
Chemical FormulaC23H28F2N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 4(Risperidone EP Impurity D) structure
EPD
利培酮杂质4(利培酮EP杂质D)Risperidone Impurity 4(Risperidone EP Impurity D)
Risperidone Impurity 4(Risperidone EP Impurity D)
CAS No.1199589-74-6
Chemical FormulaC23H27FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 5(Risperidone EP Impurity E) structure
EPE
利培酮杂质5(利培酮EP杂质E)Risperidone Impurity 5(Risperidone EP Impurity E)
Risperidone Impurity 5(Risperidone EP Impurity E)
CAS No.1346602-28-5
Chemical FormulaC24H29FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 6(Risperidone EP Impurity F) structure
EPF
利培酮杂质6(利培酮EP杂质F)Risperidone Impurity 6(Risperidone EP Impurity F)
Risperidone Impurity 6(Risperidone EP Impurity F)
CAS No.1346603-86-8
Chemical FormulaC24H27FN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 8(Risperidone EP Impurity H) structure
EPH
利培酮杂质8(利培酮EP杂质H)Risperidone Impurity 8(Risperidone EP Impurity H)
Risperidone Impurity 8(Risperidone EP Impurity H)
CAS No.158697-67-7
Chemical FormulaC23H27F2N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 9(Risperidone EP Impurity I) structure
EPI
利培酮杂质9(利培酮EP杂质I)Risperidone Impurity 9(Risperidone EP Impurity I)
Risperidone Impurity 9(Risperidone EP Impurity I)
CAS No.1329796-66-8
Chemical FormulaC35H39F2N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 10(Risperidone EP Impurity J) structure
EPJ
利培酮杂质10(利培酮EP杂质J)Risperidone Impurity 10(Risperidone EP Impurity J)
Risperidone Impurity 10(Risperidone EP Impurity J)
CAS No.1346606-24-3
Chemical FormulaC35H40F2N6O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 11(Risperidone EP Impurity K) structure
EPK
利培酮杂质11(利培酮EP杂质K)Risperidone Impurity 11(Risperidone EP Impurity K)
Risperidone Impurity 11(Risperidone EP Impurity K)
CAS No.106266-09-5
Chemical FormulaC23H28N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 12(Risperidone EP Impurity L) structure
EPL
利培酮杂质12(利培酮EP杂质L)Risperidone Impurity 12(Risperidone EP Impurity L)
Risperidone Impurity 12(Risperidone EP Impurity L)
CAS No.63234-80-0
Chemical FormulaC11H15ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 12 Hydrochloride(Risperidone EP Impurity L Hydrochloride) structure
EPL
利培酮杂质12盐酸盐(利培酮EP杂质L盐酸盐)Risperidone Impurity 12 Hydrochloride(Risperidone EP Impurity L Hydrochloride)
Risperidone Impurity 12 Hydrochloride(Risperidone EP Impurity L Hydrochloride)
CAS No.93076-03-0
Chemical FormulaC11H15ClN2O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 13 Monomer (Risperidone EP Impurity M) structure
EPM
利培酮杂质13 单体 (利培酮EP杂质M)Risperidone Impurity 13 Monomer (Risperidone EP Impurity M)
Risperidone Impurity 13 Monomer (Risperidone EP Impurity M)
CAS No.84163-77-9
Chemical FormulaC12H13FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 4-d4(Risperidone EP Impurity D-d4) structure
EPD-D4
利培酮杂质4-d4(利培酮EP杂质D-d4)Risperidone Impurity 4-d4(Risperidone EP Impurity D-d4)
Risperidone Impurity 4-d4(Risperidone EP Impurity D-d4)
CAS No.1346598-47-7
Chemical FormulaC23H23D4FN4O2
Purity>95%询价On request
Risperidone impurity 01 structure
01
利培酮杂质01Risperidone impurity 01
Risperidone impurity 01
CAS No.146801-00-5
Chemical FormulaC9H14ClNO3
Purity>95%现货In stock
10mg25mg50mg100mg
Risperidone Impurity 2 (Cis Risperidone N-Oxide) structure
2
利培酮杂质2 (顺式利培酮氮氧化物)Risperidone Impurity 2 (Cis Risperidone N-Oxide)
Risperidone Impurity 2 (Cis Risperidone N-Oxide)
CAS No.1894509-66-0
Chemical FormulaC23H27FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 2 (Trans Risperidone N-Oxide) structure
2
利培酮杂质2 (反式利培酮氮氧化物)Risperidone Impurity 2 (Trans Risperidone N-Oxide)
Risperidone Impurity 2 (Trans Risperidone N-Oxide)
CAS No.2987295-42-9
Chemical FormulaC23H27FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 2 (Risperidone N-Oxide) structure
2
利培酮杂质2 (利培酮氮氧化物)Risperidone Impurity 2 (Risperidone N-Oxide)
Risperidone Impurity 2 (Risperidone N-Oxide)
CAS No.832747-55-4
Chemical FormulaC23H27FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 14 structure
14
利培酮杂质14Risperidone Impurity 14
Risperidone Impurity 14
CAS No.913728-82-2
Chemical FormulaC23H25FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 15(Risperidone Metabolite) structure
15
利培酮杂质15(利培酮代谢物)Risperidone Impurity 15(Risperidone Metabolite)
Risperidone Impurity 15(Risperidone Metabolite)
CAS No.152542-00-2
Chemical FormulaC23H28FN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 16 structure
16
利培酮杂质16Risperidone Impurity 16
Risperidone Impurity 16
CAS No.2231638-02-9
Chemical FormulaC23H28FN4O2+·I-
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 17 structure
17
利培酮杂质17Risperidone Impurity 17
Risperidone Impurity 17
CAS No.106266-11-9
Chemical FormulaC23H28N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 20 structure
20
利培酮杂质20Risperidone Impurity 20
Risperidone Impurity 20
CAS No.1301724-91-3
Chemical FormulaC23H27FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 22 structure
22
利培酮杂质22Risperidone Impurity 22
Risperidone Impurity 22
CAS No.1391053-34-1
Chemical FormulaC23H27FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 23 structure
23
利培酮杂质23Risperidone Impurity 23
Risperidone Impurity 23
CAS No.147663-04-5
Chemical FormulaC23H27FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 25 structure
25
利培酮杂质25Risperidone Impurity 25
Risperidone Impurity 25
CAS No.832747-59-8
Chemical FormulaC11H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 26 structure
26
利培酮杂质26Risperidone Impurity 26
Risperidone Impurity 26
CAS No.168906-58-9
Chemical FormulaC23H25FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 27 structure
27
利培酮杂质27Risperidone Impurity 27
Risperidone Impurity 27
CAS No.138271-01-9
Chemical FormulaC24H29FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 28 structure
28
利培酮杂质28Risperidone Impurity 28
Risperidone Impurity 28
CAS No.1005191-81-0
Chemical FormulaC23H27FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 29 structure
29
利培酮杂质29Risperidone Impurity 29
Risperidone Impurity 29
CAS No.1246817-15-1
Chemical FormulaC24H30N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 30 structure
30
利培酮杂质30Risperidone Impurity 30
Risperidone Impurity 30
CAS No.106266-08-4
Chemical FormulaC24H25FN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 31 structure
31
利培酮杂质31Risperidone Impurity 31
Risperidone Impurity 31
CAS No.70381-58-7
Chemical FormulaC11H16N2O
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 32 structure
32
利培酮杂质32Risperidone Impurity 32
Risperidone Impurity 32
CAS No.439082-09-4
Chemical FormulaC12H11FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 33 structure
33
利培酮杂质33Risperidone Impurity 33
Risperidone Impurity 33
CAS No.2416230-38-9
Chemical FormulaC12H12FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 34 structure
34
利培酮杂质34Risperidone Impurity 34
Risperidone Impurity 34
CAS No.41078-70-0
Chemical FormulaC11H11ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 37 (Mixture of E/Z-isomers) structure
37
利培酮杂质37 (混合E/Z构型)Risperidone Impurity 37 (Mixture of E/Z-isomers)
Risperidone Impurity 37 (Mixture of E/Z-isomers)
CAS No.2470243-12-8
Chemical FormulaC25H27FN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Risperidone Impurity 23-d4 structure
23-D4
利培酮杂质23-d4Risperidone Impurity 23-d4
Risperidone Impurity 23-d4
CAS No.1215454-04-8
Chemical FormulaC23H23D4FN4O3
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

利培酮 —— 研究文献与合成路线Risperidone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 利培酮 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Risperidone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability indicating HPLC determination of risperidone in bulk drug and pharmaceutical formulations
    Dedania ZR, Dedania RR, Sheth NR, et al. · International journal of analytical chemistry · 2011 · 被引 8cited 8
  2. Bacterial degradation of risperidone and paliperidone in decomposing blood
    Butzbach DM, Stockham PC, Kobus HJ, et al. · Journal of forensic sciences · 2013 · 被引 22cited 22
  3. Identification and characterization of major degradation products of risperidone in bulk drug and pharmaceutical dosage forms
    Tomar RS, Joseph TJ, Murthy AS, et al. · Journal of pharmaceutical and biomedical analysis · 2004 · 被引 12cited 12
  4. High performance liquid chromatographic and thin layer densitometric methods for the determination of risperidone in the presence of its degradation products in bulk powder and in tablets
    El-Sherif ZA, El-Zeany B, El-Houssini OM · Journal of pharmaceutical and biomedical analysis · 2005 · 被引 10cited 10
  5. Thermal properties and morphology changes in degradation process of poly(L-lactide-co-glycolide) matrices with risperidone
    Turek A, Kasperczyk J, Jelonek K, et al. · Acta of bioengineering and biomechanics · 2015 · 被引 6cited 6
  6. Structural studies of impurities of risperidone by hyphenated techniques
    Sattanathan P, Babu JM, Vyas K, et al. · Journal of pharmaceutical and biomedical analysis · 2006 · 被引 8cited 8

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR PREPARING RISPERIDONE
    VANIERSCHOT RONNY · 公开号 WO2009077551WO2009077551 · 2009
  2. Process for the preparation of risperidone
    ZHANG GUILING, ZHU YIDONG, FAN CHUANWEN, ZHANG MINGHUI, et al. · 公开号 GB2464854GB2464854 · 2010
  3. PROCESS FOR THE PREPARATION OF RISPERIDONE
    ZHANG GUILING, ZHU YIDONG, FAN CHUANWEN, ZHANG MINGHUI, et al. · 公开号 WO2009012721WO2009012721 · 2009
  4. PROCESS FOR PREPARATION OF RISPERIDONE
    ZHANG GUILING, ZHU YIDONG, FAN CHUANWEN, ZHANG MINGHUI, et al. · 公开号 US2010130740US2010130740 · 2010
  5. A PROCESS FOR THE PREPARATION OF RISPERIDONE
    BALLA VENKATA SASIDHAR, UPPARAPALLI SAMPATHKUMAR, VELUPPILLAI LOGANATHAN, SIVALINGAM LAKSHMI, et al. · 公开号 WO2007093870WO2007093870 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

利培酮 杂质谱研究要点Risperidone — impurity profiling notes

下面这些是拿到 利培酮 的 37 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 37 impurity entries for Risperidone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances